These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1611798)

  • 1. Tc-99m HMDP uptake by the kidney in sickle cell disease.
    Binnur K; Firat G; Sukran T; Metin E
    Clin Nucl Med; 1992 Mar; 17(3):236. PubMed ID: 1611798
    [No Abstract]   [Full Text] [Related]  

  • 2. Poor renal uptake of technetium-99m-DMSA and technetium-99m-MDP in a patient with Fanconi syndrome and near normal glomerular filtration rate.
    Kim SE; Cho JT; Lee DS; Chung JK; Kim S; Lee MC; Lee JS; Koh CS
    J Korean Med Sci; 1994 Feb; 9(1):29-34. PubMed ID: 8068216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal Tc-99m-methylene diphosphonate accumulation in the kidneys of children with sickle cell disease.
    Sty JR; Babbitt DP; Sheth K
    Clin Nucl Med; 1980 Oct; 5(10):445-7. PubMed ID: 7408346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse splenic Tc-99m MDP uptake in hypersplenic patient.
    Yapar AF; Aydin M; Reyhan M
    Ann Nucl Med; 2004 Dec; 18(8):703-5. PubMed ID: 15682853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m MDP bone scintigraphy shows multiple abnormalities in sickle cell disease.
    Adams BK; Parkar S; Al-Haider ZY
    Arch Dis Child; 2003 Jul; 88(7):631. PubMed ID: 12818915
    [No Abstract]   [Full Text] [Related]  

  • 7. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver uptake and increased renal uptake of Tc-99m HMDP in a patient with iron overload.
    Ohta H
    Clin Nucl Med; 2001 Feb; 26(2):164-5. PubMed ID: 11201486
    [No Abstract]   [Full Text] [Related]  

  • 9. Splenic accumulation of [99mTc]methylene diphosphonate in sickle cell-thalassemia disease.
    Georgiou E; Gogou L; Alevizaki C; Proukakis C
    Int J Nucl Med Biol; 1983; 10(4):269-70. PubMed ID: 6229503
    [No Abstract]   [Full Text] [Related]  

  • 10. Spleen Uptake on a Bone Scan.
    Kaur H; Muhleman M; Balon HR
    J Nucl Med Technol; 2017 Sep; 45(3):245-246. PubMed ID: 28611233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different findings in Tc-99m MDP bone scintigraphy of patients with sickle cell disease: report of three cases.
    Cerci SS; Suslu H; Cerci C; Yildiz M; Ozbek FM; Balci TA; Yesildag A; Canatan D
    Ann Nucl Med; 2007 Jul; 21(5):311-4. PubMed ID: 17634851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental demonstration of cerebral infarction on bone scintigraphy in sickle cell disease.
    Hung GL; Stewart CA; Yeo E; Ansari AN; Wang A; Greenfield L
    Clin Nucl Med; 1990 Oct; 15(10):671-2. PubMed ID: 2225666
    [No Abstract]   [Full Text] [Related]  

  • 13. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
    Wulfrank DA; Schelstraete KH; Small F; Fallais CJ
    Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging.
    Kobayashi H; Shigeno C; Sakahara H; Hosono M; Hosono M; Yao ZS; Endo K; Konishi J
    J Nucl Med; 1994 Sep; 35(9):1482-4. PubMed ID: 8071696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontal and orbital bone infarctions causing periorbital swelling in patients with sickle cell anemia.
    Garty I; Koren A; Garzozi H
    Arch Ophthalmol; 1984 Oct; 102(10):1486-8. PubMed ID: 6237632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Scintigraphic appearances of Gaucher's disease].
    Okada J; Uchiyama G; Hayakawa K; Araki T; Hayashi S; Yamada K; Seto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 May; 45(5):717-20. PubMed ID: 3863094
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios.
    Buell U; Kirsch CM; Kleinhans E; Jäger B
    J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased renal parenchymal accumulation of Tc-99m HDP in kidney contusion.
    Salimi Z; Vas W; Tang-Barton P; Suresh P; Carlin B
    Clin Nucl Med; 1984 Oct; 9(10):574-6. PubMed ID: 6488654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable uptake feature of focal nodular hyperplasia in Tc-99m phytate hepatic scintigraphy/single-photon emission computed tomography-A parametric analysis.
    Hsu YL; Chen YW; Lin CY; Lai YC; Chen SC; Lin ZY
    Kaohsiung J Med Sci; 2015 Dec; 31(12):621-5. PubMed ID: 26709223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.